A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291.

McArthur, J C; Yiannoutsos, C; Simpson, D M; Adornato, B T; Singer, E J; Hollander, H; Marra, C; Rubin, M; Cohen, B A; Tucker, T; Navia, B A; Schifitto, G; Katzenstein, D; Rask, C; Zaborski, L; Smith, M E; Shriver, S; Millar, L; Clifford, D B; Karalnik, I J

McArthur, J C; Yiannoutsos, C; Simpson, D M; Adornato, B T; Singer, E J; Hollander, H; Marra, C; Rubin, M; Cohen, B A; Tucker, T; Navia, B A; Schifitto, G; Katzenstein, D; Rask, C; Zaborski, L; Smith, M E; Shriver, S; Millar, L; Clifford, D B; Karalnik, I J.

Affiliation

McArthur JC; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA. jm@jhmi.edu

Neurology ; 54(5): 1080-8, 2000 Mar 14.

Article in En | MEDLINE | ID: mdl-10720278

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Peripheral Nervous System Diseases / Nerve Growth Factor Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Neurology Year: 2000 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Search on Google

Add to My VHL

XML

PubMed Links